annual EBITDA:
-$141.79M-$32.04M(-29.19%)Summary
- As of today (June 30, 2025), ORIC annual EBITDA is -$141.79 million, with the most recent change of -$32.04 million (-29.19%) on December 31, 2024.
- During the last 3 years, ORIC annual EBITDA has fallen by -$63.81 million (-81.84%).
- ORIC annual EBITDA is now -560.46% below its all-time high of -$21.47 million, reached on December 31, 2018.
Performance
ORIC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$32.42M+$6.85M(+17.45%)Summary
- As of today (June 30, 2025), ORIC quarterly EBITDA is -$32.42 million, with the most recent change of +$6.85 million (+17.45%) on March 31, 2025.
- Over the past year, ORIC quarterly EBITDA has dropped by -$3.69 million (-12.83%).
- ORIC quarterly EBITDA is now -431.06% below its all-time high of -$6.10 million, reached on March 1, 2019.
Performance
ORIC quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$145.47M-$3.69M(-2.60%)Summary
- As of today (June 30, 2025), ORIC TTM EBITDA is -$145.47 million, with the most recent change of -$3.69 million (-2.60%) on March 31, 2025.
- Over the past year, ORIC TTM EBITDA has dropped by -$32.42 million (-28.68%).
- ORIC TTM EBITDA is now -2283.27% below its all-time high of -$6.10 million, reached on March 1, 2019.
Performance
ORIC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ORIC EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.2% | -12.8% | -28.7% |
| 3 y3 years | -81.8% | -40.9% | -71.8% |
| 5 y5 years | -414.8% | -263.0% | -379.1% |
ORIC EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -81.8% | at low | -58.5% | +17.4% | -72.6% | at low |
| 5 y | 5-year | -414.8% | at low | -263.0% | +17.4% | -379.1% | at low |
| alltime | all time | -560.5% | at low | -431.1% | +17.4% | -2283.3% | at low |
ORIC EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$32.42M(-17.4%) | -$145.47M(+2.6%) |
| Dec 2024 | -$141.79M(+29.2%) | -$39.27M(+3.2%) | -$141.79M(+6.1%) |
| Sep 2024 | - | -$38.05M(+6.4%) | -$133.69M(+7.8%) |
| Jun 2024 | - | -$35.74M(+24.4%) | -$124.06M(+9.7%) |
| Mar 2024 | - | -$28.73M(-7.8%) | -$113.05M(+3.0%) |
| Dec 2023 | -$109.75M(+27.9%) | -$31.16M(+9.6%) | -$109.75M(+9.3%) |
| Sep 2023 | - | -$28.43M(+14.9%) | -$100.45M(+8.6%) |
| Jun 2023 | - | -$24.73M(-2.7%) | -$92.50M(+4.9%) |
| Mar 2023 | - | -$25.43M(+16.2%) | -$88.22M(+2.8%) |
| Dec 2022 | -$85.80M(+10.0%) | -$21.87M(+6.8%) | -$85.80M(-0.8%) |
| Sep 2022 | - | -$20.47M(+0.1%) | -$86.50M(+2.7%) |
| Jun 2022 | - | -$20.45M(-11.1%) | -$84.27M(-0.5%) |
| Mar 2022 | - | -$23.01M(+1.9%) | -$84.66M(+8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$77.97M(+61.2%) | -$22.58M(+23.8%) | -$77.97M(+8.9%) |
| Sep 2021 | - | -$18.24M(-12.5%) | -$71.57M(+8.9%) |
| Jun 2021 | - | -$20.84M(+27.6%) | -$65.73M(+17.9%) |
| Mar 2021 | - | -$16.32M(+0.9%) | -$55.77M(+15.3%) |
| Dec 2020 | -$48.37M(+75.6%) | -$16.18M(+30.5%) | -$48.37M(+18.9%) |
| Sep 2020 | - | -$12.39M(+13.9%) | -$40.70M(+15.8%) |
| Jun 2020 | - | -$10.88M(+21.8%) | -$35.13M(+15.7%) |
| Mar 2020 | - | -$8.93M(+5.0%) | -$30.37M(+10.3%) |
| Dec 2019 | -$27.54M(+28.3%) | -$8.50M(+24.5%) | -$27.54M(+44.6%) |
| Sep 2019 | - | -$6.83M(+11.8%) | -$19.04M(+55.9%) |
| Jun 2019 | - | -$6.11M(+0.1%) | -$12.21M(+100.1%) |
| Mar 2019 | - | -$6.10M | -$6.10M |
| Dec 2018 | -$21.47M | - | - |
FAQ
- What is ORIC Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals annual EBITDA year-on-year change?
- What is ORIC Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals quarterly EBITDA year-on-year change?
- What is ORIC Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals TTM EBITDA year-on-year change?
What is ORIC Pharmaceuticals annual EBITDA?
The current annual EBITDA of ORIC is -$141.79M
What is the all time high annual EBITDA for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high annual EBITDA is -$21.47M
What is ORIC Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, ORIC annual EBITDA has changed by -$32.04M (-29.19%)
What is ORIC Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of ORIC is -$32.42M
What is the all time high quarterly EBITDA for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high quarterly EBITDA is -$6.10M
What is ORIC Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, ORIC quarterly EBITDA has changed by -$3.69M (-12.83%)
What is ORIC Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of ORIC is -$145.47M
What is the all time high TTM EBITDA for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high TTM EBITDA is -$6.10M
What is ORIC Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, ORIC TTM EBITDA has changed by -$32.42M (-28.68%)